S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Lightera Triples Submarine Fiber Capacity to Meet AI Infrastructure Demand

Lightera is committing to a major capital expansion of its submarine optical fiber manufacturing plants in Denmark and the United States. By 2029, the firm plans to nearly triple its production capacity, aiming to secure its position as a primary supplier for the surging global demand in hyperscale data center connectivity.

Lightera Triples Submarine Fiber Capacity to Meet AI Infrastructure Demand
Photo: Bio & News

The investment targets the company’s facilities in Brøndby and Norcross, Georgia, reflecting a strategic shift to accommodate the rapid growth of AI infrastructure and cloud computing. Because optical fiber is typically procured a year ahead of actual cable deployment, Lightera is scaling now to meet projected needs for the end of the decade. Chief Executive Officer Holly Hulse noted that the project is designed to deliver both increased volume and the next generation of optical technologies.

Beyond current capacity, the expansion serves as a foundation for the commercialization of multicore fiber, with initial deployments anticipated between 2029 and 2030. This transition is intended to provide a significant boost in transmission capacity for undersea networks. As part of the Furukawa Electric Group, Lightera maintains these sites as its primary global hubs for producing high-performance fiber used in the world’s most demanding communications infrastructure.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!